NasdaqCM:CDTXBiotechs
How Investors May Respond To Cidara Therapeutics (CDTX) Narrower Losses and New $178 Million Stock Shelf
On August 7, 2025, Cidara Therapeutics reported reduced net losses for the second quarter and first half of the year, and announced a shelf registration for up to US$178.53 million in common stock.
This combination of improved financial results and a large-scale fundraising registration suggests key changes to the company's operational and capital priorities.
We'll examine how the combination of shrinking losses and capital-raising plans fits into Cidara Therapeutics' investment...